Literature DB >> 16567404

Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in Fut8-/- mice.

Seung Ho Lee1, Motoko Takahashi, Koichi Honke, Eiji Miyoshi, Daisuke Osumi, Haruhiko Sakiyama, Atsuko Ekuni, Xiangchun Wang, Shinya Inoue, Jianguo Gu, Kenji Kadomatsu, Naoyuki Taniguchi.   

Abstract

alpha1,6-Fucosyltransferase (Fut8) catalyzes the transfer of a fucose residue from GDP-fucose to the innermost N-acetylglucosamine residue of N-glycans. Here we report that the loss of core fucosylation impairs the function of low-density lipoprotein (LDL) receptor-related protein-1 (LRP-1), a multifunctional scavenger and signaling receptor, resulting in a reduction in the endocytosis of insulin like growth factor (IGF)-binding protein-3 (IGFBP-3) in the cells derived from Fut8-null (Fut8-/-) mice. The reduced endocytosis was restored by the re-introduction of Fut8. Serum levels of IGFBP-3 were markedly upregulated in Fut8-/- mice. These data clearly indicate that core fucosylation is crucial for the scavenging activity of LRP-1 in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567404     DOI: 10.1093/jb/mvj039

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  18 in total

1.  E-cadherin core fucosylation regulates nuclear beta-catenin accumulation in lung cancer cells.

Authors:  Ping Hu; Bizhi Shi; Fei Geng; Chunyi Zhang; Wei Wu; Xing Zhong Wu
Journal:  Glycoconj J       Date:  2008-06-15       Impact factor: 2.916

2.  Negative feedback regulation of Wnt signaling via N-linked fucosylation in zebrafish.

Authors:  Lei Feng; Hao Jiang; Peng Wu; Florence L Marlow
Journal:  Dev Biol       Date:  2014-09-18       Impact factor: 3.582

3.  Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

Authors:  Liang-Jun Yan; Ming Xiao; Ran Chen; Zhiyou Cai
Journal:  Aging Neurodegener       Date:  2013-08

4.  Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.

Authors:  Motoko Takahashi; Yoshihiro Hasegawa; Yoshitaka Ikeda; Yoshinao Wada; Michiko Tajiri; Shigeru Ariki; Rina Takamiya; Chiaki Nishitani; Motoko Araki; Yoshiki Yamaguchi; Naoyuki Taniguchi; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

5.  Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in mice.

Authors:  Jonathan M Gitlin; Jonathon W Homeister; Joshua Bulgrien; Jessica Counselman; Linda K Curtiss; John B Lowe; William A Boisvert
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

6.  From the gamma-glutamyl cycle to the glycan cycle: a road with many turns and pleasant surprises.

Authors:  Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

7.  Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.

Authors:  Jennifer L Kielczewski; Yagna P R Jarajapu; Evan L McFarland; Jun Cai; Aqeela Afzal; Sergio Li Calzi; Kyung Hee Chang; Todd Lydic; Lynn C Shaw; Julia Busik; Jeffrey Hughes; Arturo J Cardounel; Kenneth Wilson; Timothy J Lyons; Michael E Boulton; Robert N Mames; Tailoi Chan-Ling; Maria B Grant
Journal:  Circ Res       Date:  2009-09-17       Impact factor: 17.367

8.  Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions.

Authors:  Robert C Baxter
Journal:  J Cell Commun Signal       Date:  2013-08       Impact factor: 5.782

Review 9.  IGF binding proteins in cancer: mechanistic and clinical insights.

Authors:  Robert C Baxter
Journal:  Nat Rev Cancer       Date:  2014-04-10       Impact factor: 60.716

10.  Fucose is on the TRAIL of colon cancer.

Authors:  Robert S Haltiwanger
Journal:  Gastroenterology       Date:  2009-05-29       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.